Delivery Order SPE2DB20D1110-SPE2DB25FK17P
Award Date 6/2/25
Potential Completion Date 6/3/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $5,028.93. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania, and carries an ultimate completion date of August 12, 2025. The delivery order represents a routine pharmaceutical procurement supporting federal medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Xifaxan 550 mg tablets (60-count) valued at $17,574.14 under a firm fixed-price contract. This award, issued on August 26, 2025, represents a non-set-aside competitive procurement and is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The delivery order has an ultimate completion date of August 27,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,869.31 for 60 tablets of Xifaxan 550 mg on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 16, 2025, for 60 tablets of Xifaxan 550 mg with a ceiling value of $6,393.88. This competitive award with firm fixed pricing represents a child order under the company's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 billion global pharmaceutical support vehicle that runs through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for XIFAXAN 550 MG tablets (60-count units) by the Defense Logistics Agency on August 20, 2025, with a ceiling value of $14,102.87. This firm fixed-price, non-competitive set-aside delivery order is set to be completed by August 21, 2025, and will be performed at the awardee's Conshohocken location. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $17,148.20. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $46,987.66 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count packages) on November 28, 2025, with completion scheduled for December 1, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $3,742.92 on January 6, 2026, for the supply of Xifaxan 550 mg tablets (60-count packages) to support federal medical procurement needs. This non-competitive, firm fixed-price delivery order is funded by the Defense Logistics Agency (DLA) and is scheduled for completion by January 7, 2026. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains...
- The Defense Logistics Agency awarded a $6,885.33 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a pharmaceutical delivery under the company's existing contract vehicle with DLA. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Xifaxan 550 mg tablets in unit dose packaging (60 count) with a ceiling value of $1,625.31. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 24, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among...